Skip to main content
Premium Trial:

Request an Annual Quote

Invitae Prices Public Offering at $6 Per Share

NEW YORK (GenomeWeb) – Invitae today priced its planned public offering of about 7.3 million shares of its common stock at $6 per share. 

The gross proceeds form the offering are expected to be $44 million, up from a previous estimate of $40 million, and will be used for working capital and other general corporate purposes, the San Francisco-based genetic testing firm said in a document filed with the Securities and Exchange Commission. Additionally, proceeds may go toward acquisitions of or investments in complementary businesses, assets, technologies, or intellectual property. 

JP Morgan is the sole book-running manager for the offering. Cowen is the co-manager. Invitae has granted the underwriters a 30-day option to purchase up to nearly 1.1 million shares of its common stock at $6 per share. 

The offering is anticipated to close on or about Nov. 22. 

The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.